The study focuses on how immune cells react to amyloid-beta (Aβ) plaques, a hallmark of Alzheimer's, and how this immune response differs from the reaction to bacterial toxins. "Bacteria cannot ...

Both drugs clear the brain of a substance called beta-amyloid, which forms the sticky plaques associated with Alzheimer's. Studies show they can slow down the underlying disease process that ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.

Department of Medicine I, LMU University Hospital, Ludwig Maximillian University of Munich, Germany (S.K.S., U.G., S.M., S.K.). Department of Cardiology, Angiology ...

All activities are now available on ACC's online course, Navigating Cardiac PET Imaging: Clinical Advantages, Barriers and Cutting-Edge Applications. The free course includes eight lessons that review ...